Catalyst Wire Dossier Catalyst Wire Dossier

Levocetirizine Dihydrochloride Tablets 5 mg

levocetirizine dihydrochloride · IPCA Laboratories Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Levocetirizine Dihydrochloride Tablets 5 mg, covering 2012-12-03 to 2012-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition [Phase 1]

See pricing